Respiratory Illness Live Virus Fill / Finish Services
Ended Master IDIQ Awarded
- Awardees
- 2
- Task orders
- 0
Vehicle facts
- Opportunity
-
- 16100SOL00011 Solicitation number
- Agency
-
- Office of the Assistant Secretary for Preparedness and Response Department of Health and Human Services
- Last date to order 100% complete
- Shared ceiling
- $50,000,000.00
IDV award and task order details come from SAM.gov/FPDS.
About this vehicle
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) established a Master IDIQ on September 30, 2016, to provide fill and finish services for live virus and vectored vaccine medical countermeasures targeting respiratory illness, with a combined potential value of $50 million. Ordering closed on September 29, 2021, and the vehicle is no longer active for new task-order placement.
The vehicle supported the Biomedical Advanced Research and Development Authority's (BARDA) effort to develop manufacturing capabilities enabling live virus and vectored vaccine products to advance toward FDA licensure. The scope encompassed the specialized manufacturing step of fill and finish—the final stages of vaccine production in which bulk drug substance is filled into final containers and prepared for distribution—for medical countermeasures in the respiratory illness category.
No current task-order portfolio data, recent ordering momentum, competitive awardee information, or obligated-value details are available in the source material. The vehicle's closure to new orders four years ago eliminates it as an active pursuit path for most business development cycles, though historical awards under the vehicle remain executable if task orders were issued before the September 2021 ordering deadline and contain performance periods extending into 2026.
Description
The Biomedical Advanced Research and Development Authority (BARDA) within the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS), seeks to establish Medical Countermeasure Fill / Finish capabilities to facilitate Live Virus/ Vectored Vaccine Medical Countermeasure (MCM) product development towards licensure.
IDV awards
| Awardee | IDV award | Awarded |
|---|---|---|
| IDT Biologika GMBH | HHSO100201600020I | |
| Advanced Bioscience Laboratories, Inc. | HHSO100201600019I |
Quick answers
What is the Respiratory Illness Live Virus Fill / Finish Services contract vehicle?
Respiratory Illness Live Virus Fill / Finish Services is an indefinite delivery, indefinite quantity (IDIQ) contract vehicle run by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services), awarded on September 30, 2016.
Which companies hold Respiratory Illness Live Virus Fill / Finish Services?
2 companies hold Respiratory Illness Live Virus Fill / Finish Services's IDV awards, one each. The latest went to IDT Biologika GMBH on September 30, 2016.
What is the shared ceiling of Respiratory Illness Live Virus Fill / Finish Services?
Respiratory Illness Live Virus Fill / Finish Services's shared ceiling is $50,000,000.
On GovTribe
See this vehicle's full record
- Every IDV award and task order
- Funding by agency, awardee, NAICS and set-aside
- Teaming partners on this vehicle
- Ask GovTribe AI about this vehicle